Roth Capital lowered the firm’s price target on Ceragon Networks (CRNT) to $3.75 from $4 and keeps a Buy rating on the shares. The company reported “disappointing” Q2 results as key customer in India faced continued headwinds, the analyst tells investors in a research note. The firm lowered second half of 2025 estimates for Ceragon but believes this is the sales trough. The company’s North America and private networks are well positioned for 2026, contends Roth.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNT:
- Ceragon Networks Reports Q2 2025 Financial Results Amid Strategic Growth
- Ceragon Networks sees second half of FY25 revenue consistent with first half
- Ceragon Networks reports Q2 non-GAAP EPS 3c, consensus 3c
- Is CRNT a Buy, Before Earnings?
- Ceragon Networks to Release Q2 2025 Financial Results on August 6